Literature DB >> 21246393

Urinary trypsin inhibitor attenuates lipopolysaccharide-induced acute lung injury by blocking the activation of p38 mitogen-activated protein kinase.

Xinying Zhang1, Fengqin Liu, Haiyan Liu, Hongxia Cheng, Wei Wang, Qiang Wen, Yulin Wang.   

Abstract

OBJECTIVE: To investigate the protective effect of urinary trypsin inhibitor (UTI) in a rat model of lipopolysaccharide (LPS)-induced acute lung injury (ALI) and the underlying molecular mechanism.
METHODS: Rats were randomly assigned into three groups: control group, LPS treatment group and LPS/UTI treatment group. The serum concentrations of tumor necrosis factor (TNF)-α and interleukin (IL)-10 were measured by ELISA. The expression of p38 mitogen-activated protein kinase (MAPK) in lung tissues was determined by Western blot analysis.
RESULTS: Administration of UTI reduced the lung wet/dry weight ratio and ameliorated the tissue damage. In the LPS/UTI treatment group, levels of TNF-α were significantly lower than those in the LPS treatment group, while the levels of IL-10 were significantly higher than those in the LPS treatment group. Western blot analysis revealed that UTI inhibited the phosphorylation of p38 MAPK in lung tissues.
CONCLUSIONS: UTI attenuates LPS-induced ALI, probably by adjusting the balance between proinflammatory and anti-inflammatory cytokines. The mechanism responsible for the decreased TNF-α expression may be related to the inhibitory effect of UTI on p38 MAPK activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21246393     DOI: 10.1007/s00011-010-0305-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  35 in total

Review 1.  Signalling pathways of the TNF superfamily: a double-edged sword.

Authors:  Bharat B Aggarwal
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

2.  Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway.

Authors:  D Yoshinari; I Takeyoshi; Y Koibuchi; K Matsumoto; Y Kawashima; T Koyama; S Ohwada; Y Morishita
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

3.  Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice.

Authors:  Y Kitamura; S Hashimoto; N Mizuta; A Kobayashi; K Kooguchi; I Fujiwara; H Nakajima
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

4.  Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes.

Authors:  S Aosasa; S Ono; H Mochizuki; H Tsujimoto; C Ueno; A Matsumoto
Journal:  Shock       Date:  2001-02       Impact factor: 3.454

Review 5.  MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits.

Authors:  Bozena Kaminska
Journal:  Biochim Biophys Acta       Date:  2005-09-08

Review 6.  Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group.

Authors:  Michael A Matthay; Guy A Zimmerman; Charles Esmon; Jahar Bhattacharya; Barry Coller; Claire M Doerschuk; Joanna Floros; Michael A Gimbrone; Eric Hoffman; Rolf D Hubmayr; Mark Leppert; Sadis Matalon; Robert Munford; Polly Parsons; Arthur S Slutsky; Kevin J Tracey; Peter Ward; Dorothy B Gail; Andrea L Harabin
Journal:  Am J Respir Crit Care Med       Date:  2003-04-01       Impact factor: 21.405

7.  Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression.

Authors:  Perenlei Molor-Erdene; Kenji Okajima; Hirotaka Isobe; Mitsuhiro Uchiba; Naoaki Harada; Hiroaki Okabe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11-11       Impact factor: 4.733

8.  Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion.

Authors:  Takashi Masuda; Kiyotaka Sato; Chiharu Noda; Kazuko M Ikeda; Atsuhiko Matsunaga; Misao N Ogura; Kazuhiko Shimizu; Hiroshi Nagasawa; Narihisa Matsuyama; Tohru Izumi
Journal:  Crit Care Med       Date:  2003-07       Impact factor: 7.598

9.  Toll-like receptor 4 regulates heme oxygenase-1 expression after hemorrhagic shock induced acute lung injury in mice: requirement of p38 mitogen-activated protein kinase activation.

Authors:  Chang Chen; Yanlin Wang; Zongze Zhang; Chengyao Wang; Mian Peng
Journal:  Shock       Date:  2009-05       Impact factor: 3.454

10.  Prolonged partial liquid ventilation using conventional and high-frequency ventilatory techniques: gas exchange and lung pathology in an animal model of respiratory distress syndrome.

Authors:  K M Smith; J D Mrozek; S C Simonton; D R Bing; P A Meyers; J E Connett; M C Mammel
Journal:  Crit Care Med       Date:  1997-11       Impact factor: 7.598

View more
  14 in total

1.  Urinary trypsin inhibitor attenuated inflammatory response of patients undergoing cardiopulmonary bypass by inducing activated Treg cells.

Authors:  Xing Hao; Junyan Han; Zhichen Xing; Yu Hao; Chunjing Jiang; Jianping Zhang; Jing Yang; Xiaotong Hou
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

2.  Effect of ulinastatin, a human urinary protease inhibitor, on heatstroke-induced apoptosis and inflammatory responses in rats.

Authors:  Zhen Tao; Feng-Qing Hu; Chuan-Fen Li; Tao Zhang; Bing-Zhen Cao; Lian-Qi Cui
Journal:  Exp Ther Med       Date:  2016-11-23       Impact factor: 2.447

3.  Mesenteric lymph duct drainage attenuates acute lung injury in rats with severe intraperitoneal infection.

Authors:  Yanmin Zhang; Shukun Zhang; Naiqiang Tsui
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

4.  Ulinastatin activates haem oxygenase 1 antioxidant pathway and attenuates allergic inflammation.

Authors:  Dongmei Song; Geng Song; Yinghao Niu; Wei Song; Jiantao Wang; Lei Yu; Jianwang Yang; Xin Lv; Harry Steinberg; Shu Fang Liu; Baoshan Wang
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

5.  High level expression of bikunin in Pichia pastoris by fusion of human serum albumin.

Authors:  Xing-Hua Gou; Yu-Ying Liu; Qi-Lei Chen; Jian-Jun Tang; Da-Yu Liu; Liang Zou; Xiao-Yong Wu; Wei Wang
Journal:  AMB Express       Date:  2012-02-29       Impact factor: 3.298

6.  Effects of ulinastatin administered at different time points on the pathological morphologies of the lung tissues of rats with hyperthermia.

Authors:  Zai-Sheng Qin; Pei Tian; Xia Wu; Hong-Mei Yu; Na Guo
Journal:  Exp Ther Med       Date:  2014-04-01       Impact factor: 2.447

7.  Ulinastatin attenuates neuropathic pain induced by L5-VRT via the calcineurin/IL-10 pathway.

Authors:  Handong Ouyang; Bilin Nie; Peizong Wang; Qiang Li; Wan Huang; Wenjun Xin; Weian Zeng; Xianguo Liu
Journal:  Mol Pain       Date:  2016-05-12       Impact factor: 3.395

Review 8.  Effect of Ulinastatin in the Treatment of Postperative Cognitive Dysfunction: Review of Current Literature.

Authors:  Zheng-Tao Lv; Jun-Ming Huang; Jin-Ming Zhang; Jia-Ming Zhang; Jin-Feng Guo; An-Min Chen
Journal:  Biomed Res Int       Date:  2016-08-14       Impact factor: 3.411

9.  Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study.

Authors:  Dilip R Karnad; Rakesh Bhadade; Pradeep K Verma; Nivedita D Moulick; Mradul K Daga; Neelima D Chafekar; Shivakumar Iyer
Journal:  Intensive Care Med       Date:  2014-04-16       Impact factor: 17.440

10.  JNK inhibitor SP600125 protects against lipopolysaccharide-induced acute lung injury via upregulation of claudin-4.

Authors:  Yueliang Zheng; Meiqi Zhang; Yiming Zhao; Jie Chen; Bing Li; Wenwei Cai
Journal:  Exp Ther Med       Date:  2014-04-14       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.